[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100309083":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":21,"locations":26,"responsibleParty":42,"collaborators":44,"id":48,"slug":7,"hasResults":49,"nctId":50,"briefTitle":51,"officialTitle":52,"acronym":7,"eligibilityCriteria":53,"healthyVolunteers":49,"sex":54,"minAge":7,"maxAge":7,"enrollmentInfo":55,"targetDuration":58,"studyType":59,"phases":7,"briefSummary":60,"conditions":61,"keywords":7,"overallStatus":28,"whyStopped":7,"lastUpdateSubmitDate":68,"lastUpdatePostDateStruct":69,"startDateStruct":72,"completionDateStruct":74,"leadSponsor":76,"locationsCount":77},{"fullName":5,"class":6},"University of California, Los Angeles","OTHER",null,[9,13,16,19],{"name":10,"affiliation":11,"role":12},"Wen-Hann Tan, BMBS","Boston Children's Hospital","PRINCIPAL_INVESTIGATOR",{"name":14,"affiliation":15,"role":12},"Loren Pena, MD, PhD","Children's Hospital Medical Center, Cincinnati",{"name":17,"affiliation":18,"role":12},"Vandana Shashi, MD, PhD","Duke University",{"name":20,"affiliation":5,"role":12},"Bianca Russell, MD",[22],{"name":20,"role":23,"phone":24,"phoneExt":7,"email":25},"CONTACT","(310) 206-6581","ASXL-CHROMATIN-REGISTRY@mednet.ucla.edu",[27],{"facility":5,"status":28,"city":29,"state":30,"zip":31,"country":32,"cosmosGeoPoint":33,"geoPoint":38,"contacts":39},"RECRUITING","Los Angeles","California","90095","United States",{"type":34,"coordinates":35},"Point",[36,37],-118.24368,34.05223,{"lat":37,"lon":36},[40],{"name":20,"role":23,"phone":41,"phoneExt":7,"email":25},"310-206-6581",{"type":12,"investigatorFullName":43,"investigatorTitle":20,"investigatorAffiliation":5,"oldNameTitle":7,"oldOrganization":7},"Bianca E. Russell, MD",[45,46,47],{"name":11,"class":6},{"name":15,"class":6},{"name":18,"class":6},"100309083",false,"NCT03303716","ASXL-Related Disorders Natural History Study","Natural History Study for the ASXL-Related Disorders and Chromatinopathies","Inclusion Criteria:\n\n* Clinical or molecular diagnosis of an ASXL related disorder\n\nExclusion Criteria:\n\n* No clinical or molecular diagnosis of an ASXL related disorder","ALL",{"count":56,"type":57},200,"ESTIMATED","20 Years","OBSERVATIONAL","A registry focused on the natural history, management and treatment of patients with Bohring-Opitz Syndrome (ASXL1), Shashi-Pena Syndrome (ASXL2) and Bainbridge-Ropers Syndrome (ASXL3).",[62,63,64,65,66,67],"Bohring-Opitz Syndrome","ASXL1 Gene Mutation","Shashi-Pena Syndrome","ASXL2 Gene Mutation","Bainbridge-Ropers Syndrome","ASXL3 Gene Mutation","2025-12-18",{"date":70,"type":71},"2025-12-26","ACTUAL",{"date":73,"type":71},"2017-09-20",{"date":75,"type":57},"2037-09",{"name":5,"class":6},1]